How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology (EAPC).

DOI
Publisher DOI
PubMed ID
36098041
Abstract
A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for CVD risk factors and CVD have been observed consistently over the last few decades. Hence, achieving optimal adherence to lifestyle measures and guideline-directed medical therapy in secondary prevention and rehabilitation is a great challenge to many healthcare professionals. Therefore, in this European Association of Preventive Cardiology (EAPC) clinical consensus document a modern reappraisal of the adherence to optimal treatment is provided, together with simple, practical, and feasible suggestions to achieve this goal in the clinical setting, focusing on evidence-based concepts.
Date Issued
2023-01-24
Publication Type
Article
Subject(s)
Subjects
adherence cardiovascular disease cardiovascular risk secondary prevention
Language(s)
en
Author(s)
Pedretti, Roberto F E
Hansen, Dominique
Ambrosetti, Marco
Back, Maria
Berger, Thomas
Ferreira, Mariana Cordeiro
Cornelissen, Véronique
Davos, Constantinos H
Doehner, Wolfram
de Pablo Y Zarzosa, Carmen
Frederix, Ines
Greco, Andrea
Kurpas, Donata
Michal, Matthias
Osto, Elena
Pedersen, Susanne
Salvador, Rita Esmeralda
Simonenko, Maria
Steca, Patrizia
Thompson, David R
Abreu, Ana
Additional Credits
Journal
European journal of preventive cardiology
Publisher
SAGE Publications
ISSN
2047-4873
Access(Rights)
open.access
Show full item